AI-Designed Miniproteins Can Recognize Cancer Cells, but the Real Test Comes After Linking Them to a CAR
A research team screened thousands of computational designs to identify miniproteins capable of binding PD-L1, CD276, and VTCN1. Cell experiments showed that affinity alone is not enough to ensure effective CAR-T function; protein charge and surface expression are equally influential.